Inhibitory Effects of Polyphenols on Dietary Advanced Glycation End Products and Related Diseases: A Review

被引:0
|
作者
Kong Y. [1 ]
Liang Y. [1 ]
Xiong Q. [2 ]
Ouyang Y. [1 ]
Feng Y. [1 ]
Wu Q. [1 ]
机构
[1] Key Laboratory of Fermentation Engineering (Ministry of Education), Hubei Key Laboratory of Industrial Microbiology, Cellular Regulation and Molecular Pharmaceutic-Overseas Expertise Introduction Center for Discipline Innovation ("111 Center"), Hubei Unive
[2] Hubei Geological Survey, Wuhan
来源
Shipin Kexue/Food Science | 2022年 / 43卷 / 13期
关键词
Advanced glycation end productions; Antioxidant; Inhibition; Intestinal microflora; Polyphenols;
D O I
10.7506/spkx1002-6630-20210409-115
中图分类号
学科分类号
摘要
Advanced glycosylated end products (AGEs) can cause a variety of chronic metabolic diseases such as diabetic kidney disease, Alzheimer's disease, atherosclerosis and osteoarthritis by causing reactive oxygen species (ROS) generation and activating oxidative stress. So advanced glycation end products have long been considered potently toxic molecules that promote host cell death and contribute to organ damage in humans. Polyphenols are common secondary metabolites in nature. They have diverse structures and biological activities such as antioxidant, anti-inflammatory and anti-bacterial functions. Natural polyphenols can reduce the formation of AGEs and inhibit related diseases by capturing free radicals, blocking inflammatory signaling pathways, and interacting with microorganisms. This paper reviews the inhibitory effects of polyphenols on AGEs and related diseases, expecting to provide scientific reference for further research on the inhibition of AGEs by polyphonel. © 2022, China Food Publishing Company. All right reserved.
引用
收藏
页码:227 / 236
页数:9
相关论文
共 73 条
  • [1] LUND M N, RAY C A., Control of Maillard reactions in foods: strategies and chemical mechanisms, Journal of Agricultural and Food Chemistry, 65, 23, pp. 4537-4552, (2017)
  • [2] NOMI Y, KUDO H, MIYAMOTO K, Et al., Free advanced glycation end product distribution in blood components and the effect of genetic polymorphisms, Biochimie, 179, pp. 69-76, (2020)
  • [3] SAKASAI-SAKAI A, TAKATA T, TAKEUCHI M., Intracellular toxic advanced glycation end-products promote the production of reactive oxygen species in HepG2 Cells, International Journal of Molecular Sciences, 21, 14, (2020)
  • [4] ZHU Zongshuai, BASSEY A P, KHAN I A, Et al., Inhibitory mechanism of catechins against advanced glycation end products of glycated myofibrillar protein through anti-aggregation and antioxidation, LWT-Food Science and Technology, 147, 2, pp. 122-129, (2021)
  • [5] SREY C, HULL G L J, CONNOLLY L, Et al., Effect of inhibitor compounds on N-epsilon-(carboxymethyl)lysine (CML) and N-epsilon-(carboxyethyl)lysine (CEL) formation in model foods, Journal of Agricultural and Food Chemistry, 58, 22, pp. 12036-12041, (2010)
  • [6] WANG Wei, YAGIZ Y, BURAN T J, Et al., Phytochemicals from berries and grapes inhibited the formation of advanced glycation end-products by scavenging reactive carbonyls, Food Research International, 44, 9, pp. 2666-2673, (2011)
  • [7] LO C Y, HSIAO W T, CHEN Xiuyu, Efficiency of trapping methylglyoxal by phenols and phenolic acids, Journal of Food Science, 76, 3, pp. H90-H96, (2011)
  • [8] ARAGNO M, MASTROCOLA R., Dietary sugars and endogenous formation of advanced glycation endproducts: emerging mechanisms of disease, Nutrients, 9, 4, (2017)
  • [9] VISTOLI G, DE MADDIS D, CIPAK A, Et al., Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation[J], Free Radical Research, 47, pp. 3-27, (2013)
  • [10] VAN DER LUGT T, OPPERHUIZEN A, BAST A, Et al., Dietary advanced glycation endproducts and the gastrointestinal tract, Nutrients, 12, 9, (2020)